Literature DB >> 2725656

AIDS and the new drug injector.

S R Friedman1, D C Des Jarlais, A Neaigus, A Abdul-Quader, J L Sotheran, M Sufian, S Tross, D Goldsmith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2725656     DOI： 10.1038/339333a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

Review 1.  The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research.

Authors:  Michael C Clatts; Lloyd Goldsamt; Alan Neaigus; Dorinda L Welle
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

2.  An AIDS model with distributed incubation and variable infectiousness: applications to i.v. drug users in Latium, Italy.

Authors:  M Iannelli; R Loro; F Milner; A Pugliese; G Rabbiolo
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

3.  HIV seroprevalence among male IVDUs in Houston, Texas.

Authors:  M L Williams
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

4.  Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City.

Authors:  Pedro Mateu-Gelabert; Honoria Guarino; Lauren Jessell; Anastasia Teper
Journal:  J Subst Abuse Treat       Date:  2014-07-11

5.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

Authors:  R S Garfein; D Vlahov; N Galai; M C Doherty; K E Nelson
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

6.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors:  H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

7.  Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys.

Authors:  Sigrid Vorobjov; Don C Des Jarlais; Katri Abel-Ollo; Ave Talu; Kristi Rüütel; Anneli Uusküla
Journal:  Int J Drug Policy       Date:  2012-10-01

8.  Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.

Authors:  Alan Neaigus; Mingfang Zhao; V Anna Gyarmathy; Linda Cisek; Samuel R Friedman; Robert C Baxter
Journal:  J Urban Health       Date:  2008-03-14       Impact factor: 3.671

9.  Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.

Authors:  Alan Neaigus; V Anna Gyarmathy; Maureen Miller; Vera Frajzyngier; Mingfang Zhao; Samuel R Friedman; Don C Des Jarlais
Journal:  Drug Alcohol Depend       Date:  2007-02-07       Impact factor: 4.492

10.  Preventing HIV in injection drug users: choosing the best mix of interventions for the population.

Authors:  Amy R Wilson; James G Kahn
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.